{{Rsnum
|rsid=9790517
|Gene=TET2
|Chromosome=4
|position=105163621
|Orientation=plus
|GMAF=0.2948
|Gene_s=TET2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 60.0 | 35.4 | 4.6
| HCB | 4.4 | 46.7 | 48.9
| JPT | 20.0 | 40.0 | 40.0
| YRI | 84.1 | 14.3 | 1.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 4.4 | 46.7 | 48.9
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23535729
  |Trait=Breast cancer
  |Title=Large-scale genotyping identifies 41 new loci associated with breast cancer risk.
  |RiskAllele=T
  |Pval=4E-8
  |OR=1.05
  |ORtxt=[1.03-1.08]
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}